CEMP Key Stats
- CEMPRA, INC. Financials Yahoo 03/07 13:04 ET
- Cempra, Inc. to Present at Barclays Capital 2014 Global Healthcare Conference and 26th Annual ROTH Conference GlobeNewswire 03/06 16:05 ET
- Cempra (CEMP) Falls: Stock Plunges 12.2% - Tale of the Tape Zacks 03/03 08:35 ET
- Cempra (CEMP) Falls: Stock Plunges 12.2% Yahoo 03/03 06:07 ET
- CEMPRA, INC. Files SEC form 10-K, Annual Report Yahoo 02/28 16:14 ET
- Cempra's CEO Discusses Q4 2013 Results - Earnings Call Transcript Seeking Alpha 02/27 22:52 ET
- Cempra, Inc. Reports Fourth Quarter and Full Year 2013 Financial and Operating Results noodls 02/27 16:49 ET
- Cempra Holdings (CEMP) Posts Mixed Q4 Results Street Insider 02/27 16:17 ET
- CEMPRA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits Yahoo 02/27 16:17 ET
- Q4 2013 Cempra Inc Earnings Release - After Market Close Yahoo 02/27 07:07 ET
CEMP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cempra is up 65.23% over the last year vs S&P 500 Total Return up 24.21%, Actelion up 97.06%, and Jazz Pharmaceuticals up 155.6%.
Balance Sheet View Statement
Pro Ratings for CEMP
Pro Strategies Featuring CEMP
Did Cempra make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: North Carolina
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Cempra Inc is a clinical-stage pharmaceutical company which is developing antibiotics to meet critical unmet medical needs in the treatment of bacterial infectious diseases.